Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Cancer Discovery2011Vol. 1(6), pp. 487–495
Citations Over TimeTop 1% of 2011 papers
Himisha Beltran, David S. Rickman, Kyung Park, Sung Suk Chae, Andrea Sboner, Theresa Y. MacDonald, Yuwei Wang, Karen L. Sheikh, Stéphane Terry, Scott T. Tagawa, Rajiv Dhir, Joel B. Nelson, Alexandre de la Taille, Yves Allory, Mark Gerstein, Sven Perner, Kenneth J. Pienta, Arul M. Chinnaiyan, Yuzhuo Wang, Colin C. Collins, Martin Gleave, Francesca Demichelis, David M. Nanus, Mark A. Rubin
Abstract
We report on the largest in-depth molecular analysis of NEPC and provide new insight into molecular events involved in the progression of prostate cancer.
Related Papers
- → Dynamic Profiling of Exosomal microRNAs in Blood Plasma of Patients with Castration-Resistant Prostate Cancer(2022)10 cited
- [ASC-J9 for castration-resistant prostate cancer].(2014)
- Androgen Receptor Antagonists for the Treatment of Prostate Cancer(2012)
- → Circulating Tumor Cells in Prostate Cancer(2021)